1. Yao, Xiaosai, Hong, Jing Han, Nargund, Amrita M, Tan, Patrick, Teh, Bin Tean. 2023. PBRM1-deficient PBAF complexes target aberrant genomic loci to activate the NF-κB pathway in clear cell renal cell carcinoma. In Nature cell biology, 25, 765-777. doi:10.1038/s41556-023-01122-y. https://pubmed.ncbi.nlm.nih.gov/37095322/
2. . . Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. In Cancer cell, 32, 185-203.e13. doi:10.1016/j.ccell.2017.07.007. https://pubmed.ncbi.nlm.nih.gov/28810144/
3. Pan, Deng, Kobayashi, Aya, Jiang, Peng, Liu, X Shirley, Wucherpfennig, Kai W. 2018. A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. In Science (New York, N.Y.), 359, 770-775. doi:10.1126/science.aao1710. https://pubmed.ncbi.nlm.nih.gov/29301958/
4. Chabanon, Roman M, Morel, Daphné, Eychenne, Thomas, Lord, Christopher J, Postel-Vinay, Sophie. . PBRM1 Deficiency Confers Synthetic Lethality to DNA Repair Inhibitors in Cancer. In Cancer research, 81, 2888-2902. doi:10.1158/0008-5472.CAN-21-0628. https://pubmed.ncbi.nlm.nih.gov/33888468/